Skip to main content
Journal cover image

Delivering affordable cancer care in high-income countries.

Publication ,  Journal Article
Sullivan, R; Peppercorn, J; Sikora, K; Zalcberg, J; Meropol, NJ; Amir, E; Khayat, D; Boyle, P; Autier, P; Tannock, IF; Fojo, T; Siderov, J ...
Published in: The Lancet. Oncology
September 2011

The burden of cancer is growing, and the disease is becoming a major economic expenditure for all developed countries. In 2008, the worldwide cost of cancer due to premature death and disability (not including direct medical costs) was estimated to be US$895 billion. This is not simply due to an increase in absolute numbers, but also the rate of increase of expenditure on cancer. What are the drivers and solutions to the so-called cancer-cost curve in developed countries? How are we going to afford to deliver high quality and equitable care? Here, expert opinion from health-care professionals, policy makers, and cancer survivors has been gathered to address the barriers and solutions to delivering affordable cancer care. Although many of the drivers and themes are specific to a particular field-eg, the huge development costs for cancer medicines-there is strong concordance running through each contribution. Several drivers of cost, such as over-use, rapid expansion, and shortening life cycles of cancer technologies (such as medicines and imaging modalities), and the lack of suitable clinical research and integrated health economic studies, have converged with more defensive medical practice, a less informed regulatory system, a lack of evidence-based sociopolitical debate, and a declining degree of fairness for all patients with cancer. Urgent solutions range from re-engineering of the macroeconomic basis of cancer costs (eg, value-based approaches to bend the cost curve and allow cost-saving technologies), greater education of policy makers, and an informed and transparent regulatory system. A radical shift in cancer policy is also required. Political toleration of unfairness in access to affordable cancer treatment is unacceptable. The cancer profession and industry should take responsibility and not accept a substandard evidence base and an ethos of very small benefit at whatever cost; rather, we need delivery of fair prices and real value from new technologies.

Altmetric Attention Stats
Dimensions Citation Stats

Published In

The Lancet. Oncology

DOI

EISSN

1474-5488

ISSN

1470-2045

Publication Date

September 2011

Volume

12

Issue

10

Start / End Page

933 / 980

Related Subject Headings

  • United States
  • Socioeconomic Factors
  • Oncology & Carcinogenesis
  • Neoplasms
  • Models, Economic
  • Insurance, Health
  • Humans
  • Healthcare Disparities
  • Health Services Research
  • Health Services Misuse
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., … Aapro, M. (2011). Delivering affordable cancer care in high-income countries. The Lancet. Oncology, 12(10), 933–980. https://doi.org/10.1016/s1470-2045(11)70141-3
Sullivan, Richard, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, et al. “Delivering affordable cancer care in high-income countries.The Lancet. Oncology 12, no. 10 (September 2011): 933–80. https://doi.org/10.1016/s1470-2045(11)70141-3.
Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, et al. Delivering affordable cancer care in high-income countries. The Lancet Oncology. 2011 Sep;12(10):933–80.
Sullivan, Richard, et al. “Delivering affordable cancer care in high-income countries.The Lancet. Oncology, vol. 12, no. 10, Sept. 2011, pp. 933–80. Epmc, doi:10.1016/s1470-2045(11)70141-3.
Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M. Delivering affordable cancer care in high-income countries. The Lancet Oncology. 2011 Sep;12(10):933–980.
Journal cover image

Published In

The Lancet. Oncology

DOI

EISSN

1474-5488

ISSN

1470-2045

Publication Date

September 2011

Volume

12

Issue

10

Start / End Page

933 / 980

Related Subject Headings

  • United States
  • Socioeconomic Factors
  • Oncology & Carcinogenesis
  • Neoplasms
  • Models, Economic
  • Insurance, Health
  • Humans
  • Healthcare Disparities
  • Health Services Research
  • Health Services Misuse